Everest Organics Limited (EVERESTO.BO)
INR 251.55
(4.25%)
INR 251.55
(4.25%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 426.16 Million INR | 456.04% |
| 2022 | 87.53 Million INR | -42.3% |
| 2021 | 151.72 Million INR | -50.07% |
| 2020 | 303.86 Million INR | 8.41% |
| 2019 | 280.29 Million INR | 13.64% |
| 2018 | 246.64 Million INR | 114.85% |
| 2017 | 114.79 Million INR | 23.19% |
| 2016 | 93.18 Million INR | -71.87% |
| 2015 | 331.21 Million INR | 1.64% |
| 2014 | 325.86 Million INR | 18.42% |
| 2013 | 275.18 Million INR | 27.04% |
| 2012 | 216.61 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 43.36 Million INR | -66.2% |
| 2023 Q4 | 128.32 Million INR | 4.8% |
| 2023 Q3 | 122.44 Million INR | -32.21% |
| 2023 FY | 486.74 Million INR | 456.04% |
| 2023 Q1 | 115.17 Million INR | 2.26% |
| 2023 Q2 | 180.61 Million INR | 56.83% |
| 2022 FY | 87.53 Million INR | -42.3% |
| 2022 Q1 | 136.55 Million INR | 10.37% |
| 2022 Q2 | 176.53 Million INR | 29.28% |
| 2022 Q3 | 85.03 Million INR | -51.83% |
| 2022 Q4 | 112.62 Million INR | 32.45% |
| 2021 Q3 | 106.25 Million INR | 31.26% |
| 2021 Q1 | 129.86 Million INR | -0.32% |
| 2021 FY | 151.72 Million INR | -50.07% |
| 2021 Q2 | 80.94 Million INR | -37.67% |
| 2021 Q4 | 123.72 Million INR | 16.44% |
| 2020 Q4 | 130.27 Million INR | -11.64% |
| 2020 FY | 303.86 Million INR | 8.41% |
| 2020 Q3 | 147.43 Million INR | -23.07% |
| 2020 Q2 | 191.65 Million INR | 12.28% |
| 2020 Q1 | 170.68 Million INR | 16.45% |
| 2019 FY | 280.29 Million INR | 13.64% |
| 2019 Q2 | 159.12 Million INR | -13.64% |
| 2019 Q1 | 184.25 Million INR | 16.8% |
| 2019 Q3 | 169.58 Million INR | 6.57% |
| 2019 Q4 | 146.57 Million INR | -13.56% |
| 2018 Q3 | 169.91 Million INR | 16.41% |
| 2018 Q2 | 145.96 Million INR | 33.01% |
| 2018 Q1 | 109.74 Million INR | 46.59% |
| 2018 Q4 | 157.76 Million INR | -7.15% |
| 2018 FY | 246.64 Million INR | 114.85% |
| 2017 Q1 | 98.49 Million INR | 64.9% |
| 2017 Q4 | 74.85 Million INR | -35.24% |
| 2017 FY | 114.79 Million INR | 23.19% |
| 2017 Q3 | 115.59 Million INR | 4.74% |
| 2017 Q2 | 110.36 Million INR | 12.05% |
| 2016 Q4 | 59.73 Million INR | -43.0% |
| 2016 FY | 93.18 Million INR | -71.87% |
| 2016 Q1 | 92.14 Million INR | 10.82% |
| 2016 Q2 | 103.35 Million INR | 12.17% |
| 2016 Q3 | 104.8 Million INR | 1.4% |
| 2015 Q1 | 89.21 Million INR | -38.24% |
| 2015 Q3 | 83.83 Million INR | 44.51% |
| 2015 Q2 | 58.01 Million INR | -34.97% |
| 2015 Q4 | 83.15 Million INR | -0.82% |
| 2015 FY | 331.21 Million INR | 1.64% |
| 2014 Q4 | 144.45 Million INR | 123.16% |
| 2014 Q3 | 64.73 Million INR | 5.33% |
| 2014 FY | 325.86 Million INR | 18.42% |
| 2014 Q2 | 61.45 Million INR | 0.0% |
| 2013 Q4 | 123.94 Million INR | 126.36% |
| 2013 Q1 | 44.82 Million INR | -33.16% |
| 2013 Q3 | 54.75 Million INR | 5.99% |
| 2013 FY | 275.18 Million INR | 27.04% |
| 2013 Q2 | 51.65 Million INR | 15.23% |
| 2012 FY | 216.61 Million INR | 0.0% |
| 2012 Q4 | 67.07 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 142.31 Million INR | -199.459% |
| Checkpoint Trends Limited | 11.3 Million INR | -3668.263% |
| GUJARAT INJECT (KERALA) LTD. | 3.85 Million INR | -10960.206% |
| NATURO INDIABULL LIMITED | 21.45 Million INR | -1886.417% |
| NEXUS SURGICAL AND MEDICARE LI | 26.38 Million INR | -1515.039% |
| Rajnish Wellness Limited | 56.65 Million INR | -652.239% |
| Rama Vision Limited | 272.22 Million INR | -56.549% |
| Vivo Bio Tech Limited | 416.01 Million INR | -2.44% |